Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection risk.
Back to Lifestyle
Lifestyle
October 29, 2026 at 1:25 PM
STAT+: Vertex kidney disease drug scrutinized for infection risk
STAT News
Excerpt from STAT News.